From Medscape Oncology

Medscape Medical News from the:

35th European Society for Medical Oncology (ESMO) Congress

October 08 - 12, 2010; Milan, Italy

This coverage is not sanctioned by, nor a part of, the European Society for Medical Oncology.

Slideshow

Top News Stories From the 35th ESMO Congress: Slideshow
Positive results were seen with bevacizumab in ovarian cancer, cetuximab in triple-negative breast cancer, and abiraterone in metastatic prostate cancer.

Conference News

ESMO Italian Breast Cancer Patients Older and Diagnosed Early
Medscape Medical News, October 22, 2010
ESMO Breast-Feeding Appears Safe in Breast Cancer Survivors
Medscape Medical News, October 20, 2010
ESMO Cetuximab Does Not Add Benefit in Treatment of Advanced Colorectal Cancer
Medscape Medical News, October 19, 2010
ESMO EGFR Mutations Give Survival Benefit in Lung Cancer
Medscape Medical News, October 18, 2010
ESMO Bevacizumab Delays Disease Progression in Ovarian Cancer
Medscape Medical News, October 18, 2010
ESMO Afatinib Found to Extend Time to Progression 3-Fold in Advanced NSCLC
Medscape Medical News, October 18, 2010
ESMO EGFR Possible Therapeutic Target in Triple-Negative Breast Cancer
Medscape Medical News, October 12, 2010
ESMO Novel Agent Improves Survival in Men With Advanced Prostate Cancer
Medscape Medical News, October 11, 2010
ESMO First-Line Erlotinib Triples Progression-Free Survival in NSCLC in Chinese Population
Medscape Medical News, October 10, 2010
ESMO Chemotherapy Beyond the Third Line May Benefit Certain Patients
Medscape Medical News, October 10, 2010
ESMO Patients With Metastatic Breast Cancer Should Continue Chemotherapy
Medscape Medical News, October 10, 2010
ESMO Iniparib Improves Survival in Metastatic Triple-Negative Breast Cancer
Medscape Medical News, October 10, 2010
ESMO MetMab Plus Erlotinib Improves Survival in Subset of Patients With Lung Cancer
Medscape Medical News, October 9, 2010
ESMO BKP Provides Relief From Spinal Fractures for Patients With Metastatic Cancer
Medscape Medical News, October 9, 2010
ESMO Novel Agent Trastuzumab-DM1 Shows Efficacy in Metastatic Breast Cancer
Medscape Medical News, October 9, 2010
ESMO Practice-Changing Results to Be Presented at ESMO
Medscape Medical News, October 8, 2010
ESMO What's Hot at ESMO 2010
Medscape Medical News, September 28, 2010